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Abstract 19 
Epidemiological evidence suggests cardioprotective effects of anthocyanin consumption. This 20 
study examined the predominant strawberry anthocyanin, pelargonidin-3-O-glucoside (Pg-3-21 
glc), and three of its plasma metabolites (protocatechuic acid [PCA], 4-hydroxybenzoic acid, 22 
and phloroglucinaldehyde [PGA]) for effects on the production of selected cytokines by 23 
lipopolysaccharide-stimulated THP-1 monocytes and macrophages. Concentrations of tumor 24 
necrosis factor-α (TNF-α), interleukin (IL)-1β, IL-6, IL-8 and IL-10 were determined using a 25 
cytometric bead array kit. PCA at 0.31, 1.25 and 20 μM and PGA at 5 and 20 μM decreased 26 
the concentration of IL-6 in the monocyte cultures, but there were no effects on TNF-α, IL-1β, 27 
IL-8 and IL-10 and there were no effects of the other compounds. In the macrophage cultures, 28 
PGA at 20 μM decreased the concentrations of IL-6 and IL-10, but there was no effect on 29 
TNF-α, IL-1β and IL-8 and there were no effects of the other compounds. In conclusion, 30 
while the effects of PGA were only observed at the higher, supraphysiological concentration 31 
and are thus considered of limited physiological relevance overall, the anti-inflammatory 32 
properties of PCA were observed at both the lower, physiologically relevant, and the higher 33 
concentrations; however, effects were modest and limited to IL-6 and monocytes. These 34 
preliminary data suggest potential for physiologically attainable PCA concentrations to 35 
modulate IL-6 production by monocytes.  36 
 37 
Keywords: Anthocyanin, Cytokine, Inflammation, Pelargonidin-3-O-glucoside, Strawberry  38 
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2.1 Introduction 39 
Epidemiological evidence links anthocyanin consumption with lower risk of cardiovascular 40 
disease (CVD) [1] and CVD risk factors [2]. The mechanisms are not yet fully elucidated, but 41 
evidence suggests modulation of vascular function, platelet aggregation and inflammation [3-42 
9]. TNF-α, IL-1β, IL-6, IL-8 and IL-10 are inflammatory cytokines that play a critical role in 43 
atherosclerosis, the underlying cause of most CVDs [10]. 44 
Strawberries are particularly rich in anthocyanins, predominantly pelargonidin-3-O-glucoside 45 
(Pg-3-glc). Glucuronidated pelargonidin has been reported as the predominant metabolite in 46 
three pharmacokinetic studies [11-13], but there is ambiguity regarding the position of 47 
glucuronidation and glucuronidated pelargonidin compounds are currently commercially 48 
unavailable and hence cannot be tested in cellular models. 4-hydroxybenzoic acid (4-HBA) 49 
and protocatechuic acid (PCA) have also been reported in plasma following strawberry 50 
consumption in low micromolar concentrations (0.1-2 µM) [13-15]. In addition, it is likely 51 
that phloroglucinaldehyde (PGA) might appear in plasma following strawberry consumption, 52 
as it is a A-ring degradant, reported in plasma upon anthocyanin consumption in low to high 53 
nanomolar concentrations (20-600 nM) [16, 17]. However, most studies exploring the effect 54 
of anthocyanins to modulate cytokine secretion used unmetabolized parent anthocyanins, 55 
often at supraphysiologically high doses [3, 4]. In addition, although macrophages are an 56 
important source of inflammatory cytokines [18], there are no studies exploring the potential 57 
modulation of cytokine production by anthocyanins or their metabolites by human-derived 58 
macrophages, or studies comparing the effects in human-derived monocytes versus 59 
macrophages. Thus, the aim of this study was to examine the parent anthocyanin Pg-3-glc and 60 
three physiologically relevant plasma metabolites for effects on the production of selected 61 
4 
 
pro- and anti-inflammatory cytokines (tumor necrosis factor-α [TNF-α], interleukin [IL]-1β, 62 
IL-6, IL-8 and IL-10) in lipopolysaccharide (LPS)-induced THP-1 cells.  63 
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2.2 Materials and methods 64 
2.2.1 Chemicals and reagents 65 
Pg-3-glc was purchased from Extrasynthese (Genay, France). PCA (3,4-dihydroxybenzoic 66 
acid), 4-HBA, PGA (2,4,6-trihydroxybenzaldehyde), LPS from Escherichia coli, phorbol 12-67 
myristate 13-acetate (PMA), methanol and formic acid were purchased from Sigma-Aldrich 68 
(Dorset, United Kingdom). RPMI 1640 culture medium, fetal calf serum (FCS), penicillin 69 
and streptomycin were purchased from Lonza (Basel, Switzerland). The cytometric bead 70 
array kit to analyze cytokine concentrations was purchased from BD Biosciences (Oxford, 71 
United Kingdom). 72 
2.2.2 Preparation and culture of THP-1 cells 73 
THP-1 cells (human monocytic leukemia, ECACC 88081201) were cultured in RPMI 1640 74 
culture medium supplemented with 100 UI/mL streptomycin, 100 μg/mL penicillin and 10% 75 
(v/v) FCS at 37 °C in a humidified atmosphere of 5% CO2 and kept at a density of 2-76 
9 x 105 cells/mL. For the experiments, cells were seeded in 24 well plates at a density of 77 
1 x 106 cells/mL. For differentiation into macrophages, cells were exposed to PMA at a final 78 
concentration of 0.1 μM for 72 h [19]. Polyphenols were added to provide final 79 
concentrations of 0.08, 0.31, 1.25, 5 and 20 μM. Polyphenols were added in 20 μL of 10.98% 80 
methanol and 0.22% formic acid to produce a final concentration of 0.22% methanol and 81 
0.004% formic acid in culture. The final culture volume was 1 mL. LPS (20 μL; 1 μg/mL 82 
final concentration) was added to stimulate cytokine production. 83 
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After 24 h incubation at 37 °C in a humidified atmosphere of 5% CO2, plates were 84 
centrifuged at 260 x g for 5 min and culture supernatants were collected and stored in aliquots 85 
at −20 °C until analysis. 86 
2.2.3 Measurement of cytokine concentrations 87 
Concentrations of TNF-α, IL-1β, IL-6, IL-8 and IL-10 in the culture supernatants were 88 
measured using a cytometric bead array kit from BD Biosciences (Oxford, United Kingdom) 89 
according to the manufacturer’s instructions. Data were acquired on a BD FACS Canto™ II 90 
flow cytometer and analyzed using the BD FCAP Array v3 software. Limits of detection of 91 
the cytokine assays were 0.13 pg/mL (IL-10), 1.2 pg/mL (TNF-α and IL-8), 1.6 pg/mL (IL-6) 92 
and 2.3 pg/mL (IL-1β). 93 
2.2.4 Cytotoxicity 94 
To determine whether test compounds had any cytotoxic effects, cell viability of THP-1 95 
monocytes and macrophages was assessed using Trypan blue staining. 96 
2.2.5 Statistical analyses 97 
Results are expressed as percentage of cytokine production versus control (no polyphenols) 98 
and shown as means with their standard deviations (SD). One-way ANOVA was performed 99 
to determine whether test compounds affected the cytokine production, followed by Dunnett 100 
as post hoc analysis versus control group. Statistical analysis was performed using SPSS 21 101 
(IBM Corporation, New York, USA) and a lowered P<0.01 was considered significant to 102 
account for multiple comparisons. 103 
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2.3 Results 104 
2.3.1 Effects of Pg-3-glc, PCA, 4-HBA and PGA on viability of THP-1 105 
cells 106 
There were no cytotoxic effects of the studied compounds on THP-1 monocytes or 107 
macrophages at any of the tested doses (data not shown). 108 
2.3.2 Effects of Pg-3-glc, PCA, 4-HBA and PGA on cytokine 109 
production by THP-1 monocytes 110 
Stimulation with LPS increased IL-1β production 135-fold, TNF-α production 105-fold, IL-6 111 
production 470-fold, IL-8 production 640-fold and IL-10 production 5-fold. PCA 112 
significantly reduced IL-6 production at 0.31, 1.25 and 20 μM compared to the control 113 
cultures (all P<0.01, Table 1). PGA also significantly inhibited IL-6 production and while the 114 
effects were only significant at 5 and 20 μM (P<0.01 and P<0.001 respectively, Table 1), 115 
they were slightly more potent (production was lowered by 25-35% compared to 20% for 116 
PCA) and appeared to be concentration-dependent. There was no significant effect of any 117 
tested compound, at concentrations up to 20 μM, on the production of IL-1β, TNF-α, IL-8 or 118 
IL-10 by THP-1 monocytes (Table 1). 119 
2.3.3 Effects of Pg-3-glc, PCA, 4-HBA and PGA on cytokine 120 
production by THP-1 macrophages 121 
Stimulation with LPS increased IL-1β production 10-fold, TNF-α production 45-fold, IL-6 122 
production 220-fold, IL-8 production 80-fold and IL-10 production 5-fold. PGA was the only 123 
compound that induced significant changes in cytokine production. PGA at the highest dose 124 
8 
 
tested (20 μM) significantly lowered IL-6 production (P<0.001, Table 2), similar to the 125 
monocyte results and with a similar magnitude of effect. Furthermore, it also significantly 126 
decreased IL-10 production (20 μM; P<0.01; Table 2), an effect not observed in THP-1 127 
monocytes. There was no significant effect of any of the tested compounds, at concentrations 128 
up to 20 μM, on the production of IL-1β, TNF-α or IL-8 by THP-1 macrophages (Table 2).   129 
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Table 1 Effect of Pg-3-glc, PCA, 4-HBA and PGA on IL-1β, TNF-α, IL-6, IL-8 and IL-130 
10 production by THP-1 monocytes 131 
  Cytokine production (% of control) 
 IL-1β  TNF-α  IL-6  IL-8  IL-10  
Pg-3-glc           
0 µM 100  100  100  100  100  
0.08 µM 91.8 ± 18.9  114.2 ± 20.5  85.6 ± 17.5  108.6 ± 15.6  113.4 ± 12.4 
0.31 µM 92.7 ± 10.7  110.8 ± 20.3  78.2 ± 13.2  102.3 ± 19.6  104.0 ± 8.9  
1.25 µM 93.2 ± 8.4  112.9 ± 20.1  78.4 ± 11.8  96.1 ± 13.0  102.9 ± 10.4 
5.00 µM 92.3 ± 9.6  106.4 ± 19.4  84.5 ± 10.4  101.9 ± 12.1  102.5 ± 8.0  
20.00 µM 96.4 ± 13.9  101.1 ± 20.0  88.5 ± 18.6  103.9 ± 19.4  98.0 ± 4.9  
           
PCA           
0 µM 100  100  100  100  100  
0.08 µM 94.5 ± 7.8  103.5 ± 18.9  87.3 ± 7.0  110.3 ± 13.0  107.0 ± 6.9  
0.31 µM 97.7 ± 7.5  93.4 ± 15.3  77.8 ± 9.7 ** 98.2 ± 7.1  104.6 ± 5.9  
1.25 µM 104.9 ± 5.2  92.9 ± 10.7  77.2 ± 10.2 ** 106.0 ± 9.0  105.4 ± 7.0  
5.00 µM 95.2 ± 12.8  85.7 ± 7.9  88.3 ± 15.9  100.5 ± 14.9  99.0 ± 9.5  
20.00 µM 89.3 ± 19.3  85.9 ± 11.0  79.8 ± 14.1 ** 102.4 ± 10.1  93.6 ± 7.6  
           
4-HBA           
0 µM 100  100  100  100  100  
0.08 µM 83.4 ± 7.6  104.2 ± 21.2  99.1 ± 14.5  94.0 ± 18.2  99.9 ± 8.6  
0.31 µM 97.7 ± 10.4  109.3 ± 22.5  90.9 ± 5.1  91.3 ± 15.7  104.8 ± 8.9  
1.25 µM 97.3 ± 15.3  110.4 ± 26.4  91.9 ± 3.6  90.9 ± 16.5  101.8 ± 6.9  
5.00 µM 100.2 ± 8.6  107.2 ± 19.5  85.1 ± 21.6  93.5 ± 17.8  103.7 ± 8.0  
20.00 µM 105.7 ± 13.0  114.2 ± 16.5  93.4 ± 25.0  90.2 ± 22.2  102.3 ± 7.1  
            
PGA           
0 µM 100  100  100  100  100  
0.08 µM 97.2 ± 11.6  111.4 ± 21.3  90.0 ± 16.2  103.2 ± 13.7  110.6 ± 13.1 
0.31 µM 102.1 ± 7.4  107.5 ± 21.4  91.9 ± 17.2  96.8 ± 21.1  104.6 ± 11.0 
1.25 µM 106.5 ± 11.8  112.9 ± 18.9  79.7 ± 10.6  97.0 ± 13.8  101.2 ± 9.0  
5.00 µM 110.4 ± 12.3  117.0 ± 22.1  73.6 ± 6.9 ** 95.2 ± 20.6  97.1 ± 9.2  
20.00 µM 106.2 ± 12.6  111.6 ± 21.7  65.9 ± 17.6 *** 94.6 ± 19.3  95.6 ± 6.1  
THP-1 monocytes (1 x 106 cells/mL) were treated with Pg-3-glc, PCA, 4-HBA, PGA or vehicle control at 132 
concentrations of 0-20 µM, prior to lipopolysaccharide stimulation (1 μg/mL) and incubated for 24 h at 37 °C. 133 
Cytokine concentrations in the culture supernatants were measured using a cytometric bead array kit. Results are 134 
expressed as percentage of cytokine concentration vs. control (no polyphenols). Data are represented as the 135 
mean ± SD of six independent experiments. Data were analyzed by one-way ANOVA and Dunnett post hoc 136 
analysis, where applicable, and a lowered P<0.01 was considered significant to account for multiple 137 
comparisons. Statistically significant differences are denoted as **P<0.01 vs. control; ***P<0.001 vs. control. 138 
4-HBA, 4-hydroxybenzoic acid; IL, interleukin; PCA, protocatechuic acid; Pg-3-glc, pelargonidin-3-O-139 
glucoside; PGA, phloroglucinaldehyde; TNF-α, tumor necrosis factor-α.  140 
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Table 2 Effect of Pg-3-glc, PCA, 4-HBA and PGA on IL-1β, TNF-α, IL-6, IL-8 and IL-141 
10 production by THP-1 macrophages 142 
  Cytokine production (% of control) 
  IL-1β  TNF-α  IL-6  IL-8  IL-10  
Pg-3-glc           
0 µM 100  100  100  100  100  
0.08 µM 113.2 ± 18.8  117.3 ± 31.0  113.5 ± 24.7  111.4 ± 12.8  100.9 ± 17.4 
0.31 µM 111.6 ± 15.1  115.8 ± 22.2  108.0 ± 21.6  106.5 ± 12.2  87.3 ± 15.1  
1.25 µM 108.9 ± 12.3  112.4 ± 16.0  101.4 ± 24.1  105.8 ± 16.9  88.0 ± 16.8  
5.00 µM 107.8 ± 16.7  110.5 ± 24.5  101.6 ± 20.1  103.4 ± 16.1  80.1 ± 13.5  
20.00 µM 99.2 ± 14.7  106.0 ± 18.1  107.7 ± 19.8  102.9 ± 11.8  84.3 ± 16.0  
           
PCA           
0 µM 100  100  100  100  100  
0.08 µM 102.7 ± 9.3  117.2 ± 23.2  116.2 ± 25.2  106.5 ± 16.1  100.8 ± 12.0 
0.31 µM 103.8 ± 10.0  101.0 ± 18.6  111.7 ± 22.9  104.4 ± 14.1  85.0 ± 24.9  
1.25 µM 100.8 ± 6.8  96.5 ± 26.0  101.8 ± 23.6  101.7 ± 12.5  84.1 ± 22.2  
5.00 µM 100.9 ± 10.8  101.7 ± 17.5  107.2 ± 23.9  98.7 ± 12.0  83.2 ± 19.6  
20.00 µM 99.1 ± 9.9  100.6 ± 22.9  88.6 ± 19.4  103.7 ± 12.0  77.8 ± 27.2  
           
4-HBA           
0 µM 100  100  100  100  100  
0.08 µM 108.7 ± 17.9  115.3 ± 28.7  107.9 ± 21.4  111.3 ± 13.6  106.2 ± 13.5 
0.31 µM 107.4 ± 17.1  112.2 ± 27.7  104.2 ± 17.0  103.4 ± 16.6  93.1 ± 15.0  
1.25 µM 110.2 ± 18.2  109.6 ± 29.3  101.1 ± 14.4  102.6 ± 19.5  90.8 ± 19.0  
5.00 µM 109.9 ± 16.8  97.8 ± 27.3  97.4 ± 27.4  103.0 ± 15.2  88.5 ± 16.5  
20.00 µM 112.2 ± 18.4  109.7 ± 27.9  94.7 ± 25.8  95.2 ± 16.1  94.8 ± 11.6  
            
PGA           
0 µM 100  100  100  100  100  
0.08 µM 106.6 ± 7.4  113.9 ± 21.7  109.5 ± 17.6  110.9 ± 16.4  110.3 ± 21.2 
0.31 µM 111.4 ± 11.9  107.6 ± 18.0  95.7 ± 18.6  104.8 ± 11.9  77.6 ± 15.3  
1.25 µM 112.3 ± 8.7  100.5 ± 18.7  79.7 ± 16.0  103.1 ± 21.2  72.1 ± 16.0  
5.00 µM 110.9 ± 16.3  98.5 ± 21.4  71.8 ± 19.1  106.3 ± 12.3  70.9 ± 19.1  
20.00 µM 113.7 ± 17.9  110.5 ± 23.7  58.8 ± 25.6 *** 115.6 ± 23.2  65.4 ± 26.2 ** 
THP-1 monocytes (1 x 106 cells/mL) were converted to macrophages through exposure to 0.1 μM phorbol-12-143 
myristate-13-acetate for 72 h. THP-1 macrophages were treated with Pg-3-glc, PCA, 4-HBA, PGA or vehicle 144 
control at concentrations of 0-20 μM, prior to lipopolysaccharide stimulation (1 μg/mL) and incubated for 24 h 145 
at 37 °C. Cytokine concentrations in the culture supernatants were measured using a cytometric bead array kit. 146 
Results are expressed as percentage of cytokine concentration vs. control (no polyphenols). Data are represented 147 
as the mean ± SD of six independent experiments. Data were analyzed by one-way ANOVA and Dunnett post 148 
hoc analysis, where applicable, and a lowered P<0.01 was considered significant to account for multiple 149 
comparisons. Statistically significant differences are denoted as **P<0.01 vs. control; ***P<0.001 vs. control. 150 
4-HBA, 4-hydroxybenzoic acid; IL, interleukin; PCA, protocatechuic acid; Pg-3-glc, pelargonidin-3-O-151 
glucoside; PGA, phloroglucinaldehyde; TNF-α, tumor necrosis factor-α.  152 
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2.4 Discussion 153 
This study aimed to compare the effects of Pg-3-glc and its plasma metabolites PCA, 4-HBA 154 
and PGA on cytokine secretion by LPS-stimulated THP-1 cells. There were modest anti-155 
inflammatory effects of some of the tested compounds in THP-1 monocytes, with PCA and 156 
PGA inhibiting IL-6 production, but there were no effects on TNF-α, IL-1β, IL-8 and IL-10 157 
and there were no effects of the other compounds. The effects in macrophages were slightly 158 
different. Whilst PGA inhibited IL-6 production by THP-1 derived macrophages, it also 159 
inhibited IL-10 production, which was not observed in THP-1 monocytes. 160 
IL-6 is generally classified as a pro-inflammatory cytokine and the inhibition of LPS-161 
stimulated IL-6 secretion by PCA and PGA in the monocyte cultures and PGA in the 162 
macrophage cultures is a novel observation. Importantly, the inhibitory effect of PCA was 163 
observed at physiologically attainable [14, 15, 17] low micromolar concentrations. Taken 164 
together with previous investigations, the current results contribute to the suggestion that 165 
PCA acts on multiple cell types involved in IL-6 secretion during atherosclerosis, including 166 
endothelial [7] and dendritic cells [4], although the latter experiment applied a 167 
supraphysiological PCA dose of 25 μM. It is important to note in this context that the 168 
presence of PCA in plasma has also been reported following ingestion of other anthocyanins 169 
[42, 53, 54], the flavonol quercetin [55] and it is also naturally present in several other dietary 170 
sources, such as chicory, olives, raspberries, dates and onions [2, 56, 57], but it is currently 171 
not known what proportion in plasma comes from these sources and what proportion 172 
indirectly as a metabolite. Whilst the bioactivity of PGA on IL-6 was a novel observation, the 173 
effect was only significant at the higher 5 and 20 µM concentrations. As levels in circulation 174 
remain below micromolar concentration (even after anthocyanin consumption), this finding is 175 
likely of limited physiological relevance [16, 17]. 176 
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IL-10 is generally classified as an anti-inflammatory cytokine. PGA decreased the production 177 
of IL-10 in THP-1 macrophages, suggesting a pro-inflammatory tendency and this seems to 178 
contrast its IL-6-reducing (i.e. anti-inflammatory) effect. However, the IL-10 decreasing 179 
effect was observed only at high concentrations that are unlikely to be achieved in vivo. To 180 
our knowledge, no other studies have investigated the effect of PGA on IL-10 production by 181 
monocytes or macrophages. There is evidence to suggest that the inhibition of IL-6 and IL-10 182 
production could be linked in a way that inhibition of IL-6 production could indirectly inhibit 183 
IL-10 production [20]. There were no effects of any of the other tested compounds on IL-10 184 
levels, which is in line with experiments on the effect of PCA in human monocyte-derived 185 
dendritic cells [4] and Pg-3-glc, PCA and 4-HBA in THP-1 monocytes [6]. Beneficial effects 186 
on IL-10 production were observed in human leukocytes with tea-derived polyphenols [21], 187 
suggesting differential bioactivity of different polyphenol classes, although effects were only 188 
observed at the higher, supraphysiological polyphenol doses (10 and 20 µM). 189 
4-HBA had no effect on the secretion of any of the cytokines. Consistent with this, 4-HBA at 190 
0.1-10 µM was previously reported to have no effect on TNF-α secretion by LPS-stimulated 191 
THP-1 monocytes. Interestingly, however, this study is indicative of additive/synergistic 192 
effects between polyphenols as an inhibitory effect on TNF-α was reported when 4-HBA was 193 
coincubated with PCA or PCA plus vanillic acid, none of which was bioactive in isolation [6]. 194 
Furthermore, the reported IL-1β-reducing effect of 4-HBA is in contrast to the present study, 195 
despite both studies employing similar concentrations of 4-HBA, the same cell line and 196 
similar culture conditions, but the current experiment conducted no preincubation with test 197 
compounds. In peripheral blood mononuclear cells, 1 µM 4-HBA had no effect on IL-1β or 198 
IL-6 levels in accordance with the present data, but a modest 10% increase in TNF-α levels 199 
was observed, which could be related to the differences in cell type and culture conditions. 200 
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The discrepant findings regarding the effect of 4-HBA on IL-1β and TNF-α merit further 201 
investigation. 202 
In this study only PCA and PGA modulated cytokine secretion, whose effects were targeted 203 
towards IL-6 and IL-10, while having no impact on the other cytokines. In contrast, 4-HBA 204 
and Pg-3-glc did not affect any of the cytokines tested. These results suggest that at least two 205 
hydroxyl groups (either ortho or para to each other) might be required for bioactivity. In line 206 
with this suggestion, potent radical scavenging activity of polyphenols was previously linked 207 
to the presence of an ortho-dihydroxy group [22] and was furthermore correlated with the 208 
number of hydroxyl groups on the B-ring [23]. In order to identify chemical structures or 209 
properties required for anti-inflammatory effects, screening studies with a larger number of 210 
related compounds are required. 211 
2.5 Conclusion 212 
In conclusion, the data suggest that PCA may possess anti-inflammatory properties through 213 
modulation of IL-6 production, which could contribute to protective effects in inflammatory 214 
diseases. Importantly, this action was observed at physiologically attainable concentrations, 215 
although the effect was modest and limited to monocytes. The IL-6 and IL-10-reducing 216 
effects of PGA were only observed at the higher, supraphysiological concentration and are 217 
thus considered of limited physiological relevance. Pg-3-glc and 4-HBA had no effect on any 218 
of the tested cytokines. Future studies should focus on screening a larger number of related 219 
compounds in order to identify chemical structures or properties required for anti-220 
inflammatory effects and underlying mechanisms.   221 
14 
 
2.6 Acknowledgments 222 
The authors declare no conflicts of interest related to this experiment. 223 
 224 
Funding: This work was supported by a BBSRC CASE studentship with GlaxoSmithKline 225 
as industrial sponsor. The sponsors had no role in the interpretation of the study. The study 226 
design was approved by GlaxoSmithKline. Apart from that, the sponsors had no role in the 227 
collection, analysis and interpretation of the data, in preparation of the manuscript and in the 228 
decision to publish.  229 
15 
 
2.7 References 230 
[1] Cassidy A, Mukamal KJ, Liu L, Franz M, Eliassen AH, Rimm EB. High anthocyanin intake is associated 231 
with a reduced risk of myocardial infarction in young and middle-aged women. Circulation. 2013;127:188-96. 232 
[2] Jennings A, Welch AA, Fairweather-Tait SJ, Kay C, Minihane A-M, Chowienczyk P, et al. Higher 233 
anthocyanin intake is associated with lower arterial stiffness and central blood pressure in women. Am J Clin 234 
Nutr. 2012;96:781-8. 235 
[3] Noratto GD, Angel-Morales G, Talcott ST, Mertens-Talcott SU. Polyphenolics from acai (Euterpe oleracea 236 
Mart.) and red muscadine grape (Vitis rotundifolia) protect human umbilical vascular endothelial cells (HUVEC) 237 
from glucose- and lipopolysaccharide (LPS)-induced inflammation and target MicroRNA-126. J Agric Food 238 
Chem. 2011;59:7999-8012. 239 
[4] Del Corno M, Varano B, Scazzocchino B, Filesi C, Masella R, Gessani S. Protocatechuic acid inhibits 240 
human dentritic cell functional activation: Role of PPARy up-modulation. Immunobiology. 2014;219:416-24. 241 
[5] Min SW, Ryu SN, Kim DH. Anti-inflammatory effects of black rice, cyanidin-3-O-beta-D-glycoside, and its 242 
metabolites, cyanidin and protocatechuic acid. Int Immunopharmacol. 2010;10:959-66. 243 
[6] di Gesso JL, Kerr JS, Zhang QZ, Raheem S, Yalamanchili SK, O'Hagan D, et al. Flavonoid metabolites 244 
reduce tumor necrosis factor-a secretion to a greater extent than their precursor compounds in human THP-1 245 
monocytes. Mol Nutr Food Res. 2015;59:1143-54. 246 
[7] Amin HP, Czank C, Raheem S, Zhang QZ, Botting NP, Cassidy A, et al. Anthocyanins and their 247 
physiologically relevant metabolites alter the expression of IL-6 and VCAM-1 in CD40L and oxidized LDL 248 
challenged vascular endothelial cells. Mol Nutr Food Res. 2015;59:1095-106. 249 
[8] Rodriguez-Mateos A, Heiss C, Borges G, Crozier A. Berry (poly)phenols and cardiovascular health. J Agric 250 
Food Chem. 2014;62:3842-51. 251 
[9] Erlund I, Koli R, Alfthan G, Marniemi J, Puukka P, Mustonen P, et al. Favorable effects of berry 252 
consumption on platelet function, blood pressure, and HDL cholesterol. Am J Clin Nutr. 2008;87:323-31. 253 
[10] Ait-Oufella H, Taleb S, Mallat Z, Tedgui A. Recent advances on the role of cytokines in atherosclerosis. 254 
Arterioscler Thromb Vasc Biol. 2011;31:969-79. 255 
[11] Mullen W, Edwards CA, Serafini M, Crozier A. Bioavailability of pelargonidin-3-O-glucoside and its 256 
metabolites in humans following the ingestion of strawberries with and without cream. J Agric Food Chem. 257 
2008;56:713-9. 258 
[12] Sandhu AK, Huang YC, Xiao D, Park E, Edirisinghe I, Burton-Freeman B. Pharmacokinetic 259 
characterization and bioavailability of strawberry anthocyanins relative to meal intake. J Agric Food Chem. 260 
2016;64:4891-9. 261 
[13] Banaszewski K, Park E, Edirisinghe I, Cappozzo J, Burton-Freeman BM. A pilot study to investigate 262 
bioavailability of strawberry anthocyanins and characterize postprandial plasma polyphenols absorption patterns 263 
by Q-TOFLC/MS in humans. J Berry Res. 2013;3:113-26. 264 
[14] Russell WR, Scobbie L, Labat A, Duthie GG. Selective bio-availability of phenolic acids from Scottish 265 
strawberries. Mol Nutr Food Res. 2009;53:S85-S91. 266 
[15] Azzini E, Vitaglione P, Intorre F, Napolitano A, Durazzo A, Foddai MS, et al. Bioavailability of strawberry 267 
antioxidants in human subjects. Br J Nutr. 2010;104:1165-73. 268 
[16] de Ferrars RM, Cassidy A, Curtis P, Kay CD. Phenolic metabolites of anthocyanins following a dietary 269 
intervention study in post-menopausal women. Mol Nutr Food Res. 2014;58:490-502. 270 
16 
 
[17] de Ferrars RM, Czank C, Zhang Q, Botting NP, Kroon PA, Cassidy A, et al. The pharmacokinetics of 271 
anthocyanins and their metabolites in humans. Br J Pharmacol. 2014;171:3268-82. 272 
[18] Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev. 273 
2006;86:515-81. 274 
[19] Kavanagh IC, Symes CE, Renaudin P, Nova E, Mesa MD, Boukouvalas G, et al. Degree of oxidation of 275 
low density lipoprotein affects expression of CD36 and PPAR gamma, but not cytokine production, by human 276 
monocyte-macrophages. Atherosclerosis. 2003;168:271-82. 277 
[20] Steensberg A, Fischer CP, Keller C, Moller K, Pedersen BK. IL-6 enhances plasma IL-1ra, IL-10, and 278 
cortisol in humans. Am J Endocrinol Metab. 2003;285:E433-E7. 279 
[21] Crouvezier S, Powell B, Keir D, Yaqoob P. The effects of phenolic components of tea on the production of 280 
pro- and anti-inflammatory cytokines by human leukocytes in vitro. Cytokine. 2001;13:280-6. 281 
[22] Yokozawa T, Chen CP, Dong E, Tanaka T, Nonaka GI, Nishioka I. Study on the inhibitory effect of tannins 282 
and flavonoids against the 1,1-diphenyl-2-picrylhydrazyl radical. Biochem Pharmacol. 1998;56:213-22. 283 
[23] Yi L, Chen CY, Jin X, Mi MT, Yu B, Chang H, et al. Structural requirements of anthocyanins in relation to 284 
inhibition of endothelial injury induced by oxidized low-density lipoprotein and correlation with radical 285 
scavenging activity. FEBS Lett. 2010;584:583-90. 286 
 287 
